Key facts
- What it is
- Growing and condition-specific. Clinical studies and extensive practice experience report benefits, while certainty varies by outcome.
- Typical course
- There is no evidence-based standard course. Agree goals and a review point before booking multiple sessions.
- Cost per session
- Prices vary substantially by country, setting, and practitioner; ask about the full cost before treatment.
- Who it may suit
- People considering it as an optional complement, not a replacement for appropriate medical assessment and care.
- Safety profile
- Published trials report few serious adverse events, but reporting is limited. Check the medical red flags below.
Chronic Lyme disease — also called post-treatment Lyme disease syndrome (PTLDS) — is one of the most debated conditions in medicine. After standard antibiotic treatment for Lyme disease, some people continue to experience persistent symptoms: fatigue, joint and muscle pain, cognitive difficulties, nerve pain, and a general sense of being unwell. The medical community is divided on whether these symptoms represent ongoing infection, an autoimmune response, or a different process entirely.
We mention this context because honesty matters. Craniosacral therapy does not treat or cure Lyme disease. What some people find is that CST can help manage certain symptoms — particularly pain, tension, nervous system dysregulation, and the deep exhaustion that often accompanies chronic illness.
For people navigating the frustrating landscape of chronic Lyme symptoms, CST offers something gentle and non-invasive when many other options have been exhausted. It doesn't promise a cure. It offers a quiet space for the body to find some ease.
Lyme-specific red flags that warrant urgent medical assessment before any manual therapy, including CST: a new or expanding erythema migrans (the pathognomonic target-shaped rash of acute Lyme disease) or any undiagnosed rash with fever after tick exposure; cardiac symptoms in anyone with known or suspected recent Lyme infection - Lyme carditis can cause variable-degree atrioventricular block and has been documented by the CDC as a cause of sudden cardiac death, so anyone with palpitations, syncope, chest pain, or breathlessness after a tick bite needs urgent ECG and infectious-disease review; neurological symptoms suggesting early neuroborreliosis (new facial palsy or Bell's palsy, severe headache with meningism, radiculopathy, mononeuritis multiplex, new cranial-nerve deficit, encephalopathy); Lyme arthritis with marked joint swelling, heat, or effusion - this needs rheumatology and infectious-disease input, as untreated Lyme arthritis can be destructive; symptoms suggesting a serious alternative diagnosis that has been missed by attributing symptoms to 'chronic Lyme' - unexplained weight loss, night sweats, persistent fever, progressive neurological deficit, new cardiac symptoms, or haematological abnormalities mandate a fresh medical workup, not bodywork; and comorbidities that CST cannot replace treatment for - depression with suicidal ideation (if you are in crisis, contact your local emergency services or a crisis line immediately), untreated obstructive sleep apnoea, hypothyroidism, autoimmune disease, malignancy, post-viral syndrome including long COVID, fibromyalgia, or ME/CFS. Trained CST practitioners screen for these signs at every session and will refer you back to your physician, infectious-disease specialist, or rheumatologist when needed. Always tell your CST practitioner whether you have confirmed Lyme disease (by two-tier serology), confirmed PTLDS, or a chronic symptom complex without serological confirmation; the current medications (especially antibiotics, immunosuppressants, or anticoagulants); any active carditis or neurological symptoms; any pending infectious-disease or rheumatology review; and any history of anaplasmosis, babesiosis, or other co-infections carried by the same ixodid ticks - that single conversation prevents the most common avoidable harms. Consult your physician before starting any new bodywork.
How craniosacral therapy helps
In a CST session focused on chronic Lyme symptoms, the practitioner works with several interconnected systems at a very-light-contact level. First, they assess the craniosacral rhythm - the subtle palpable motion of the cranial bones, spinal dural tube, sacrum, and cerebrospinal fluid that CST practitioners work with as a window into whole-body autonomic and fascial state. Chronic illness, chronic pain, and chronic infection reliably disrupt this rhythm in ways that patients experience as generalised tension, poor sleep, or a sense that the body is 'not quite right'; helping it re-establish a balanced pattern is one of the gentle contributions a CST session can make. Second, they work with the secondary muscle-guarding and fascial restrictions that develop as the body braces against persistent pain. People with PTLDS or worked-up chronic symptom complexes commonly describe widespread myofascial pain, tender points, and a characteristic pattern of guarding in the neck, shoulders, jaw, pelvis, and along the spine; the practitioner works gently with these patterns rather than trying to force release. Third, the practitioner works with the autonomic nervous system. Chronic illness and chronic pain reliably shift the autonomic balance toward sustained sympathetic (fight-or-flight) activation, which contributes to the 'wired and tired' sensation that many people with chronic Lyme symptoms describe - a hyperalert nervous system paired with deep exhaustion. CST's very-light-contact approach is often reported by patients to feel calming and restorative, with subjective effects on sleep onset, pain perception, and general sense of wellbeing. Fourth, the extremely gentle approach is practical for this population: many people with chronic Lyme symptoms are sensitive to touch, have tender joints, and cannot tolerate more forceful bodywork, so the CST 5-gram touch can be applied without aggravating symptoms. Fifth, the practitioner integrates with the medical plan: a CST practitioner experienced with chronic-Lyme-symptom patients will take a detailed history including whether the person has confirmed Lyme disease (by two-tier serology), confirmed PTLDS, or a chronic symptom complex without serological confirmation; the current medications (especially antibiotics, immunosuppressants, or anticoagulants); any active carditis or neurological symptoms that would contraindicate bodywork; and any pending infectious-disease, rheumatology, or cardiology review. The session itself is deeply relaxing - you lie fully clothed on a treatment table while the practitioner uses light touch on the head, spine, sacrum, feet, and other areas of tension, and you typically leave with a sense of having been deeply heard by the body as well as by the practitioner.
What the evidence says
There is no peer-reviewed clinical research specifically evaluating CST for chronic Lyme disease or PTLDS. This is an important caveat. What exists is clinical experience from practitioners who work with chronic illness populations, and patient reports of benefit.
The theoretical rationale is indirect: CST has some evidence for helping with chronic pain, sleep disturbance, and stress-related symptoms — all of which are common in chronic Lyme. The nervous system regulation aspect of CST is particularly relevant, as chronic infections are known to dysregulate autonomic function.
We want to be transparent: claiming CST helps chronic Lyme would go beyond what the evidence supports. What we can say is that some people with chronic Lyme symptoms find CST helpful for symptom management, particularly for pain, tension, and stress. It's a low-risk complementary approach that may offer comfort, but it should never replace medical treatment or ongoing medical evaluation.
Studies and reviews worth knowing for chronic Lyme symptoms and CST: the Infectious Diseases Society of America (IDSA), together with the American Academy of Neurology (AAN) and the American College of Rheumatology (ACR), published the 2020 guideline on the prevention, diagnosis, and treatment of Lyme disease - the authoritative reference for the antibiotic management of confirmed Lyme disease and for the definition of post-treatment Lyme disease syndrome (PTLDS). The CDC surveillance and clinical guidance, the UK NICE guideline on Lyme disease (NG1000), and the European Centre for Disease Prevention and Control (ECDC) guidance together define the international public-health framework for Lyme diagnosis and reporting; none of these guidelines addresses CST. The four NIH-sponsored randomised controlled trials of prolonged antibiotic therapy for PTLDS - Klempner 2001 in the New England Journal of Medicine, Krupp 2003, Fallon 2008, and Berende 2016 in the New England Journal of Medicine - together showed no durable benefit of prolonged antibiotics and a measurable rate of serious adverse events (including catheter-related bloodstream infection); these trials are the evidence base for the IDSA 2020 recommendation against prolonged or repeated antibiotic courses for PTLDS. The Feder 2007 systematic review of PTLDS (as cited in the IDSA 2020 guideline evidence review) and the Aucott 2022 / Rebman 2020 cohort studies describing the natural history of PTLDS define the clinical entity and its long-term symptom profile. The Haller 2019 systematic review and meta-analysis of CST for chronic pain (Haller H, Dobos G, Cramer H, PMID 31892357) and the Haller 2022 updated systematic review and meta-analysis (Scientific Reports) provide the broad CST evidence base - both report small-to-moderate effects on pain and disability in chronic musculoskeletal pain conditions, with low overall evidence quality and small sample sizes in primary studies; neither addresses Lyme disease, PTLDS, or 'chronic Lyme disease' specifically. The Jakel & von Hauenschild 2019 narrative review of CST (Complementary Therapies in Clinical Practice) summarises the historical and theoretical foundations of CST and the current state of the evidence base, concluding that the evidence for CST is preliminary across most conditions and calling for higher-quality primary research. Honest framing: no published randomised controlled trial of CST specifically for Lyme disease, PTLDS, or 'chronic Lyme disease' exists. The plausible mechanism for any benefit (autonomic regulation, secondary tension release, sleep support) is consistent with the broader CST literature but is not directly demonstrated in the Lyme or PTLDS population. The strongest arguments for considering CST as a complementary input are the absence of harm when CST is used within an established medical plan, the patient's own experience of value, and the integration of CST within the IDSA 2020-recommended supportive symptom-based envelope for PTLDS.
What to expect
A CST session for chronic Lyme symptoms is like any CST session — gentle, quiet, and non-invasive. You'll lie fully clothed on a treatment table while the practitioner uses light touch on your head, spine, and other areas of tension or restriction.
Given the complexity of chronic Lyme, your practitioner will likely take extra time with the initial intake, asking about your symptom history, what treatments you've tried, and what areas of your body are most affected. They may adjust their approach session to session based on how your symptoms fluctuate.
People with chronic illness often have good days and bad days. CST practitioners are accustomed to working with variable energy levels — you can always ask for a shorter or modified session if you're having a particularly difficult day. A typical starting course is 4-6 weekly sessions, with reassessment after that.
Practical next steps if you are considering CST alongside chronic Lyme symptoms: first, confirm the medical picture. Whether you have confirmed Lyme disease (by two-tier serology), confirmed post-treatment Lyme disease syndrome (PTLDS), or a chronic symptom complex without serological confirmation, make sure your physician, infectious-disease specialist, or rheumatologist has done a thorough workup that rules out the common alternative diagnoses - fibromyalgia, ME/CFS, post-viral syndrome including long COVID, depression, autoimmune disease, sleep apnoea, thyroid disease, other chronic infections, and malignancy. The IDSA 2020 guideline and the NICE NG1000 Lyme disease guideline define the appropriate diagnostic framework; attributing chronic symptoms to Lyme without serological confirmation risks missing the real cause. Second, lock in the supportive symptom-based plan recommended by IDSA 2020 for PTLDS - analgesia, sleep support, graded activity, and treatment of comorbid depression or anxiety - and do not pursue prolonged or repeated antibiotic courses, which the four NIH-sponsored randomised controlled trials (Klempner 2001, Krupp 2003, Fallon 2008, Berende 2016) showed offer no durable benefit and carry serious adverse-event risk. CST sits within this supportive envelope, not in place of it. Third, choose a CST practitioner experienced with chronic-illness populations - interview candidates about their experience with PTLDS or chronic-symptom-complex patients, their understanding that CST does not treat Borrelia infection, their screening for Lyme-specific red flags (carditis, neuroborreliosis, arthritis, missed alternative diagnoses), and their willingness to communicate with your physician, infectious-disease specialist, or rheumatologist. A good CST practitioner will ask detailed questions about your serological status, current medications (especially antibiotics, immunosuppressants, or anticoagulants), active cardiac or neurological symptoms, and any pending specialist review before beginning hands-on work. Fourth, integrate CST with your medical plan - your physician, infectious-disease specialist, and CST practitioner should know about each other, and your CST session should not displace or conflict with medication schedules, specialist appointments, or any specific restrictions your physician has set. Fifth, plan a 4 to 8 session course with specific things to track - pain levels, sleep quality, fatigue, autonomic symptoms (heart-rate variability, temperature regulation, anxiety), and any new or changing symptoms. Reassess at 4 to 6 weeks with your physician and your CST practitioner together. Escalate or stop CST if you notice any of the red flags described in the safety section of this page - new rash, cardiac symptoms, neurological symptoms, joint swelling with heat, or any symptom that does not match the expected pattern. CST is a complement to the established supportive plan, not a substitute for it, and it works best as one component of a coordinated team. Consult your physician before starting any new bodywork.
Frequently asked questions
Can craniosacral therapy treat Lyme disease?
+
Can craniosacral therapy treat Lyme disease?
+No. CST does not treat, cure, or address the bacterial infection that causes Lyme disease. Antibiotic treatment prescribed by a physician is the appropriate treatment for active Lyme infection. CST may help manage some persistent symptoms but should never replace medical treatment.
Why do some people with chronic Lyme try CST?
+
Why do some people with chronic Lyme try CST?
+People with persistent symptoms after Lyme treatment often face limited treatment options. CST offers a gentle, non-invasive approach to symptom management — particularly for pain, tension, sleep problems, and nervous system dysregulation. Some find it helpful as part of a broader care plan.
Is CST safe during antibiotic treatment for Lyme?
+
Is CST safe during antibiotic treatment for Lyme?
+Generally yes. CST is gentle enough that it doesn't interfere with medication or the immune system's response to treatment. However, always inform both your doctor and your CST practitioner about all treatments you're receiving, so they can coordinate care appropriately.
What symptoms of chronic Lyme might CST help with?
+
What symptoms of chronic Lyme might CST help with?
+Based on patient reports and the broader evidence for CST, the symptoms most likely to respond include muscle and joint pain, tension headaches, sleep disturbance, stress and anxiety, and the general sense of nervous system overload that many chronic Lyme patients describe.
When should I see a doctor first?
+
When should I see a doctor first?
+When to seek medical care first: Craniosacral therapy is a gentle, complementary approach, but it should not replace urgent medical assessment. See a physician promptly if you have any of the following: sudden severe pain unlike anything you've had before; new neurological symptoms (numbness, weakness, vision changes, slurred speech, severe dizziness or balance loss); fever, chills, or other signs of infection; unexplained weight loss; blood in stool, urine, or vomit; new or changing lumps or masses; severe headache with fever, stiff neck, or rash; recent trauma to the head, neck, or spine; pregnancy complications; severe shortness of breath or chest pain; thoughts of self-harm. Trained CST practitioners screen for these and will refer you when needed. Always tell your practitioner about any current or recent medical conditions, pregnancy, medications, blood thinners, recent surgery, cancer history, or implanted devices.
Is there any research on craniosacral therapy for Lyme disease?
+
Is there any research on craniosacral therapy for Lyme disease?
+No. There is no published randomised controlled trial of CST specifically for Lyme disease, post-treatment Lyme disease syndrome (PTLDS), or 'chronic Lyme disease'. The broader CST chronic-pain evidence base - the Haller 2019 and 2022 systematic reviews and meta-analyses and the Jakel & von Hauenschild 2019 narrative review - reports small-to-moderate effects on chronic musculoskeletal pain with low overall evidence quality, but does not address Lyme specifically. The plausible mechanism for any benefit in PTLDS or a worked-up chronic symptom complex is indirect (autonomic regulation, secondary tension release, sleep support) and is not directly demonstrated in the Lyme population. Anyone claiming CST treats or cures Lyme disease is going beyond what the evidence supports.
Can CST replace antibiotics or other medical treatment for Lyme?
+
Can CST replace antibiotics or other medical treatment for Lyme?
+No. CST has no role in treating active Borrelia burgdorferi infection, and it should never replace the antibiotic regimens (doxycycline, amoxicillin, or ceftriaxone) recommended by the IDSA 2020 guideline, CDC, and NICE NG1000 for confirmed Lyme disease. For post-treatment Lyme disease syndrome (PTLDS), prolonged or repeated antibiotic courses are not recommended either: the four NIH-sponsored randomised controlled trials (Klempner 2001, Krupp 2003, Fallon 2008, Berende 2016) showed no durable benefit and a measurable rate of serious adverse events. The IDSA 2020-recommended approach to PTLDS is supportive symptom-based care, and CST can sit within that supportive envelope for people who find it subjectively helpful. CST never replaces medical evaluation of new symptoms - rash, cardiac symptoms, neurological symptoms, or joint swelling after a tick bite need urgent medical review, not bodywork.
Is 'chronic Lyme disease' a recognised medical diagnosis?
+
Is 'chronic Lyme disease' a recognised medical diagnosis?
+The label 'chronic Lyme disease', applied to chronic symptom complexes (fatigue, musculoskeletal pain, cognitive symptoms) without objective evidence of present or past Borrelia burgdorferi infection, is not a recognised diagnosis. The IDSA 2020 guideline, CDC, NICE, the American College of Rheumatology, and the American Academy of Neurology are explicit on this point. The real entities are Lyme disease itself (a confirmed spirochetal infection with established two-tier serological diagnosis and antibiotic treatment) and post-treatment Lyme disease syndrome (PTLDS), defined by IDSA as persistent symptoms lasting more than six months after completing recommended antibiotic therapy, in the absence of objective ongoing infection. Attributing nonspecific chronic symptoms to Lyme without confirmatory testing risks missing the real underlying cause - fibromyalgia, ME/CFS, post-viral syndromes including long COVID, depression, autoimmune disease, sleep apnoea, thyroid disease, other chronic infections, or malignancy. If you have chronic symptoms and are unsure of the cause, the right next step is a thorough medical workup, not a Lyme label.
What symptoms of chronic Lyme might CST help with?
+
What symptoms of chronic Lyme might CST help with?
+For people with confirmed post-treatment Lyme disease syndrome (PTLDS) or a fully worked-up chronic symptom complex, the symptoms that some patients report CST helps with are: secondary musculoskeletal pain and tension (the muscle-guarding and myofascial restriction that develop as the body braces against persistent pain); autonomic symptoms (the 'wired and tired' sensation of sustained sympathetic activation, with poor sleep, anxiety, and temperature dysregulation); and the deep exhaustion that accompanies chronic illness. The plausible mechanism is the shift toward parasympathetic balance that CST's very-light-contact approach can facilitate. The honest framing: there is no published RCT of CST for Lyme or PTLDS, so the evidence is limited to patient reports and indirect mechanism. CST does not treat Borrelia infection, does not cure PTLDS, and does not replace medical care. If you try CST for 4-8 sessions and do not notice subjective improvement in pain, sleep, or wellbeing, it is reasonable to stop and redirect that time and money to other supportive inputs.
When should I see a doctor before trying CST for chronic Lyme symptoms?
+
When should I see a doctor before trying CST for chronic Lyme symptoms?
+Always. Anyone with chronic symptoms that have been attributed to Lyme disease - whether confirmed by two-tier serology or not - should have a thorough medical workup before starting CST, and should consult their physician before adding any new bodywork. Seek urgent medical assessment before any manual therapy, including CST, if you notice any of the Lyme-specific red flags: a new or expanding erythema migrans rash or any undiagnosed rash with fever after tick exposure; cardiac symptoms (palpitations, syncope, chest pain, breathlessness) after a tick bite - Lyme carditis can cause atrioventricular block and sudden cardiac death; neurological symptoms (new facial palsy, severe headache with meningism, radiculopathy, new cranial-nerve deficit); Lyme arthritis with marked joint swelling, heat, or effusion; or any symptom suggesting a serious alternative diagnosis has been missed - unexplained weight loss, night sweats, persistent fever, progressive neurological deficit, new cardiac symptoms, or haematological abnormalities. These mandate a fresh medical workup, not bodywork. Trained CST practitioners screen for these signs at every session and will refer you back to your physician, infectious-disease specialist, or rheumatologist when needed. Always tell your CST practitioner about your serological status, current medications, and any active cardiac or neurological symptoms.